Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tanya Chandra & Rohit Aggarwal. (2020) Clinical trials and novel therapeutics in dermatomyositis. Expert Opinion on Emerging Drugs 25:3, pages 213-228.
Read now
Read now
Articles from other publishers (5)
Chieh-Lin (Stanley) Wu, Adrian V. Cioanca, Maria C. Gelmi, Li Wen, Nick Di Girolamo, Ling Zhu, Riccardo Natoli, R Max Conway, Constantinos Petsoglou, Martine J. Jager, Peter J. McCluskey & Michele C. Madigan. (2023) The multifunctional human ocular melanocortin system. Progress in Retinal and Eye Research 95, pages 101187.
Crossref
Crossref
George Iliopoulos & Dimitrios Daoussis. (2023) FDA-APPROVED INDICATIONS OF ADRENOCORTICOTROPIC HORMONE (ACTH) AS A DRUG: DOES IT HAVE A PLACE IN DISEASE MANAGEMENT TODAY?. Central Asian Journal of Medical Hypotheses and Ethics 3:4, pages 220-231.
Crossref
Crossref
Cynthia Girman, Mary P. Panaccio, Kyle Hayes, John Niewoehner & George J. Wan. (2022) Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review. Advances in Therapy 39:7, pages 3072-3087.
Crossref
Crossref
Winnie W. Nelson, Michael J. Philbin, Jack R. Gallagher, Kylee Heap, Susan Carroll & George J. Wan. (2017) A Retrospective Medical Record Review of Utilization Patterns and Medical Resource Use Associated with Repository Corticotropin Injection among Patients with Rheumatologic Diseases in the United States. Rheumatology and Therapy 4:2, pages 465-474.
Crossref
Crossref
. (2017) Adalimumab/infliximab. Reactions Weekly 1636:1, pages 15-15.
Crossref
Crossref